Bacterial Vaginosis

USPSTF: Pregnant women may not need vaginosis screening

The recommendation updates the task force's 2008 guideline with a further literature review but is not different, wrote a team led by USPSTF chair Dr. Douglas Owens of Stanford University. The group found that bacterial vaginosis screening just doesn't seem to offer an advantage for avoiding preterm delivery, which has been associated with the condition.

April 7, 2020

Can cheap test prevent newborn deaths? | Amino acid desmosine as biomarker in aneurysms | Brouhaha over DTC genetic tests

Dear LabPulse Member,

October 21, 2019

NIH study finds vaginal bacteria could predict preterm births

A research group led by Jennifer Fettweis, PhD, of Virginia Commonwealth University analyzed data from a subpopulation of over 1,500 women who participated in the NIH Common Fund's Human Microbiome Project. The researchers collected samples of vaginal bacteria from 45 pregnant women who delivered their babies preterm and compared them with samples from 90 women who delivered at full term. Almost 80% of the 135 women were African American.

May 29, 2019

FDA clears 2 Hologic tests for yeast infections

Hololgic's Aptima BV test is for bacterial vaginosis (BV), and the Aptima CV/TV assay is designed for detecting Candida vaginitis (CV) and Trichomomas vaginalis (TV). These three are the most common types of vaginitis, accounting for 90% of cases, and coinfection is common, the company noted.

May 28, 2019